Viewing Study NCT00353366


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2026-01-01 @ 10:58 PM
Study NCT ID: NCT00353366
Status: COMPLETED
Last Update Posted: 2021-03-16
First Post: 2006-07-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-11-16
Start Date Type: ACTUAL
Primary Completion Date: 2010-03-31
Primary Completion Date Type: ACTUAL
Completion Date: 2010-07-17
Completion Date Type: ACTUAL
First Submit Date: 2006-07-17
First Submit QC Date: None
Study First Post Date: 2006-07-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-07-07
Results First Submit QC Date: None
Results First Post Date: 2011-08-03
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-02-23
Last Update Post Date: 2021-03-16
Last Update Post Date Type: ACTUAL